SCHEDULE: Universal Insurance Holdings Executive Chairman Sean Downes Amends 13D Filing, Details Share Ownership and Recent Transactions

Sentiment:

Schedule 13D Amendment


Executive Chairman Sean P. Downes updated his Schedule 13D filing for Universal Insurance Holdings, Inc., disclosing a 6.6% beneficial ownership stake and detailing recent share sales, option exercises, and new restricted stock awards.

Summary

  • Sean P. Downes, Executive Chairman of Universal Insurance Holdings, Inc., beneficially owns 1,888,710 shares of Common Stock, representing 6.6% of the outstanding shares as of July 28, 2025.
  • His beneficial ownership includes options to purchase 534,325 shares exercisable within 60 days and 300,000 restricted shares (July 2025 RSA).
  • The 300,000 restricted shares will vest in annual increments of 60,000 shares on July 28, 2026, July 28, 2027, July 28, 2028, July 28, 2029, and December 31, 2029.
  • On June 12, 2025, Mr. Downes sold 25,000 shares at an average price of $26.9112 per share.
  • On June 13, 2025, Mr. Downes sold an additional 25,000 shares at an average price of $26.475 per share.
  • On July 23, 2025, he received 687,960 shares from the exercise of vested stock options, with 546,115 shares withheld for exercise prices and tax obligations.
  • Mr. Downes acquired shares through his employment agreements and open market purchases.
  • He currently has no plans or proposals to change the company's structure, management, capitalization, dividend policy, or engage in extraordinary corporate transactions.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While there were executive share sales, which can be viewed negatively, these were offset by a significant new restricted stock award and the exercise of options, indicating continued long-term commitment and alignment of interests. The explicit statement of no plans for disruptive corporate changes also contributes to a stable outlook.

Positives

  • Executive Chairman Sean P. Downes maintains a significant beneficial ownership stake of 6.6% in the company, aligning his interests with shareholders.
  • The award of 300,000 restricted shares (July 2025 RSA) demonstrates continued long-term incentive and commitment from a key executive.
  • The filing explicitly states that Mr. Downes has no present plans to change the company's corporate structure, management, capitalization, or dividend policy, indicating stability.

Negatives

  • Executive Chairman Sean P. Downes sold a total of 50,000 shares of Common Stock in June 2025 (25,000 shares on June 12 at an average of $26.9112 and 25,000 shares on June 13 at an average of $26.475).

Risks

  • No specific risks related to the company's operations or financial health are detailed in this Schedule 13D filing, as its primary purpose is to report beneficial ownership and related transactions.

Future Outlook

Sean P. Downes explicitly states that he does not currently have any plans or proposals that would result in the acquisition or disposition of additional securities, extraordinary corporate transactions, material asset sales, changes in the board or management, material changes in capitalization or dividend policy, or other material changes to the corporate structure or governance documents.

Management Comments

  • Mr. Downes does not presently have any plan(s) or proposal(s) which relates to or would result in any of the following: the acquisition or disposition by any person of additional securities of the issuer; an extraordinary corporate transaction involving the issuer or its subsidiaries; a sale or transfer of a material amount of the issuer's or its subsidiaries' assets; any change in the present board of directors or management of the issuer; any material change in the present capitalization or dividend policy of the issuer; any other material change in the issuer's corporate structure; any changes to the issuer's charter, bylaws or instruments corresponding thereto which may impede the acquisition of control by any person; causing a class of securities of the issuer to be delisted from a national securities exchange or cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; or a class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934.

Industry Context

This Schedule 13D amendment primarily concerns the beneficial ownership and recent transactions of a key executive, Sean P. Downes, within Universal Insurance Holdings, Inc. It does not provide information directly related to broader industry trends or competitive dynamics within the insurance sector.

Related Party Transactions

  • Acquisition of shares through Mr. Downes' employment with the Company, including pursuant to an Executive Chairman Agreement.
  • Receipt of shares via Non-qualified Stock Option Agreements, Restricted Stock Unit Agreements, and Performance Shares Agreements.
  • Award of 300,000 restricted shares (July 2025 RSA) as part of his compensation.

Stakeholder Impact

  • Shareholders: The filing provides transparency regarding a significant executive's ownership stake and recent trading activity, which can influence investor perception. The continued long-term equity awards align executive interests with shareholder value.
  • Employees: The filing details executive compensation mechanisms (stock options, restricted stock units), which may reflect broader company compensation strategies.

Next Steps

  • Vesting of 60,000 restricted shares on July 28, 2026.
  • Vesting of 60,000 restricted shares on July 28, 2027.
  • Vesting of 60,000 restricted shares on July 28, 2028.
  • Vesting of 60,000 restricted shares on July 28, 2029.
  • Vesting of 60,000 restricted shares on December 31, 2029.

Key Dates

DateDescription
2020-03-02Company's Annual Report on Form 10-K filed with the SEC, referenced for Form of Restricted Stock Unit Agreement.
2021-07-14Company's Registration Statement on Form S-8 filed, referenced for Universal Insurance Holdings, Inc. 2021 Omnibus Incentive Plan.
2022-05-02Company's Quarterly Report on Form 10-Q filed, referenced for Form of Notice of Grant on Non-Qualified Stock Option and Terms and Conditions of Non-Qualified Stock Option under the 2021 Omnibus Incentive Plan.
2022-07-29Company's Quarterly Report on Form 10-Q filed, referenced for Form of Notice of Grant on Performance Share Units and Terms and Conditions of Performance Share Units under the 2021 Omnibus Incentive Plan.
2023-05-02Company's Quarterly Report on Form 10-Q filed, referenced for Form of Notice of Grant of Restricted Stock Units Pursuant to the 2021 Omnibus Incentive Plan.
2023-07-31Company's Quarterly Report on Form 10-Q filed, referenced for Form of Notice of Grant of Restricted Stock and Terms and Conditions of Restricted Stock Award under the 2021 Omnibus Incentive Plan.
2024-02-28Company's Annual Report on Form 10-K filed, referenced for Form of Restricted Stock Unit Agreement.
2024-07-30Company's Quarterly Report on Form 10-Q filed, referenced for Form of Notice of Grant of Restricted Stock and Terms and Conditions of Restricted Stock Award under the 2021 Omnibus Incentive Plan.
2024-10-30Company's Quarterly Report on Form 10-Q filed, referenced for Form of Universal Insurance Holdings, Inc. Performance Shares Agreement and Restricted Shares Agreement under the 2021 Omnibus Incentive Plan for grants in 2024.
2025-06-12Sean P. Downes sold 25,000 shares of Common Stock at an average price of $26.9112.
2025-06-13Sean P. Downes sold 25,000 shares of Common Stock at an average price of $26.475.
2025-07-23Sean P. Downes received 687,960 shares of Common Stock from the exercise of vested stock options.
2025-07-28Date of event requiring filing of this statement; Sean P. Downes was awarded 300,000 restricted shares (July 2025 RSA); 28,318,558 shares of Common Stock outstanding used for percentage calculation.
2025-07-30Date of filing of this Schedule 13D Amendment No. 6; Company's Quarterly Report on Form 10-Q filed, referenced for Amended and Restated Executive Chairman Agreement and Form of Notice of Grant of Restricted Stock and Terms and Conditions of Restricted Stock Award under the 2021 Omnibus Incentive Plan in 2025.
2026-07-28First vesting date for 60,000 shares of the July 2025 RSA.
2027-07-28Second vesting date for 60,000 shares of the July 2025 RSA.
2028-07-28Third vesting date for 60,000 shares of the July 2025 RSA.
2029-07-28Fourth vesting date for 60,000 shares of the July 2025 RSA.
2029-12-31Final vesting date for 60,000 shares of the July 2025 RSA.

Recommendation

hold

The filing primarily provides an update on an executive's beneficial ownership and recent transactions, which includes both share sales and new equity awards. While the sales might raise some questions, the substantial new restricted stock award and the executive's continued significant stake suggest ongoing commitment. The filing explicitly states no plans for major corporate changes, indicating stability. Without broader financial performance data or strategic shifts, a 'hold' recommendation is appropriate, as the information presented does not strongly compel a 'buy' or 'sell' decision but rather confirms an executive's ongoing involvement and compensation structure.

Keywords

Universal Insurance Holdings, Sean P. Downes, Schedule 13D, Beneficial Ownership, Common Stock, Executive Chairman, Stock Options, Restricted Stock Units, Share Sales, Corporate Governance, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.